Genovis AB (publ.) Sustainability Profile
Genovis AB (publ.), headquartered in Sweden, is a pioneering biotechnology company that has been at the forefront of the life sciences industry since its founding in 2001. With a strong focus on developing innovative tools for biopharmaceutical research, Genovis operates primarily in Europe and North America, catering to a global clientele. The company is renowned for its unique enzyme technologies that facilitate the analysis and characterisation of biopharmaceuticals, particularly monoclonal antibodies. Genovis's core products, including its proprietary GlycoConnect™ and FabRICATOR™ platforms, stand out for their ability to streamline workflows and enhance the accuracy of protein analysis. With a commitment to advancing biotherapeutics, Genovis has established a solid market position, recognised for its contributions to the field and its ongoing innovation in enzyme development.
DitchCarbon Score
How does Genovis AB (publ.)'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genovis AB (publ.)'s score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Genovis AB (publ.)'s reported carbon emissions
Genovis AB (publ.), headquartered in Sweden, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that Genovis AB may not yet have established formal climate initiatives or targets, which is increasingly common in the biotechnology sector as companies assess their environmental impact. As the industry moves towards greater transparency and accountability regarding carbon emissions, it is essential for organisations like Genovis AB to consider developing and communicating their climate strategies to align with global sustainability goals.
How Carbon Intensive is Genovis AB (publ.)'s Industry?
How Carbon Intensive is Genovis AB (publ.)'s Location?
Genovis AB (publ.)'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Genovis AB (publ.) has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
